MovDisordV3, PubMed, Corpus, bibRecord, 004976

Selegiline, fluoxetine, and depression in Parkinson's disease.

Identifieur interne : 004976 ( PubMed/Corpus ); précédent : 004975; suivant : 004977

Selegiline, fluoxetine, and depression in Parkinson's disease.

Auteurs : J C Garcia-Monco ; A. Padierna ; M. Gomez Beldarrain

Source :

Movement disorders : official journal of the Movement Disorder Society [ 0885-3185 ] ; 1995.

RBID : pubmed:7651457

English descriptors

KwdEn :
- Aged, Depressive Disorder (drug therapy), Dose-Response Relationship, Drug, Drug Administration Schedule, Drug Therapy, Combination, Female, Fluoxetine (adverse effects), Fluoxetine (therapeutic use), Humans, Parkinson Disease (drug therapy), Selegiline (adverse effects), Selegiline (therapeutic use).
MESH :
- chemical , adverse effects : Fluoxetine, Selegiline.
- drug therapy : Depressive Disorder, Parkinson Disease.
- chemical , therapeutic use : Fluoxetine, Selegiline.
- Aged, Dose-Response Relationship, Drug, Drug Administration Schedule, Drug Therapy, Combination, Female, Humans.

DOI: 10.1002/mds.870100322
PubMed: 7651457

Links to Exploration step

pubmed:7651457

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Selegiline, fluoxetine, and depression in Parkinson's disease.</title>
<author><name sortKey="Garcia Monco, J C" sort="Garcia Monco, J C" uniqKey="Garcia Monco J" first="J C" last="Garcia-Monco">J C Garcia-Monco</name>
</author>
<author><name sortKey="Padierna, A" sort="Padierna, A" uniqKey="Padierna A" first="A" last="Padierna">A. Padierna</name>
</author>
<author><name sortKey="Gomez Beldarrain, M" sort="Gomez Beldarrain, M" uniqKey="Gomez Beldarrain M" first="M" last="Gomez Beldarrain">M. Gomez Beldarrain</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="1995">1995</date>
<idno type="RBID">pubmed:7651457</idno>
<idno type="pmid">7651457</idno>
<idno type="doi">10.1002/mds.870100322</idno>
<idno type="wicri:Area/PubMed/Corpus">004976</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Selegiline, fluoxetine, and depression in Parkinson's disease.</title>
<author><name sortKey="Garcia Monco, J C" sort="Garcia Monco, J C" uniqKey="Garcia Monco J" first="J C" last="Garcia-Monco">J C Garcia-Monco</name>
</author>
<author><name sortKey="Padierna, A" sort="Padierna, A" uniqKey="Padierna A" first="A" last="Padierna">A. Padierna</name>
</author>
<author><name sortKey="Gomez Beldarrain, M" sort="Gomez Beldarrain, M" uniqKey="Gomez Beldarrain M" first="M" last="Gomez Beldarrain">M. Gomez Beldarrain</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="1995" type="published">1995</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term>
<term>Depressive Disorder (drug therapy)</term>
<term>Dose-Response Relationship, Drug</term>
<term>Drug Administration Schedule</term>
<term>Drug Therapy, Combination</term>
<term>Female</term>
<term>Fluoxetine (adverse effects)</term>
<term>Fluoxetine (therapeutic use)</term>
<term>Humans</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Selegiline (adverse effects)</term>
<term>Selegiline (therapeutic use)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Fluoxetine</term>
<term>Selegiline</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Depressive Disorder</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Fluoxetine</term>
<term>Selegiline</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Dose-Response Relationship, Drug</term>
<term>Drug Administration Schedule</term>
<term>Drug Therapy, Combination</term>
<term>Female</term>
<term>Humans</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">7651457</PMID>
<DateCreated><Year>1995</Year>
<Month>09</Month>
<Day>28</Day>
</DateCreated>
<DateCompleted><Year>1995</Year>
<Month>09</Month>
<Day>28</Day>
</DateCompleted>
<DateRevised><Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0885-3185</ISSN>
<JournalIssue CitedMedium="Print"><Volume>10</Volume>
<Issue>3</Issue>
<PubDate><Year>1995</Year>
<Month>May</Month>
</PubDate>
</JournalIssue>
<Title>Movement disorders : official journal of the Movement Disorder Society</Title>
<ISOAbbreviation>Mov. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>Selegiline, fluoxetine, and depression in Parkinson's disease.</ArticleTitle>
<Pagination><MedlinePgn>352</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Garcia-Monco</LastName>
<ForeName>J C</ForeName>
<Initials>JC</Initials>
</Author>
<Author ValidYN="Y"><LastName>Padierna</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Gomez Beldarrain</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>UNITED STATES</Country>
<MedlineTA>Mov Disord</MedlineTA>
<NlmUniqueID>8610688</NlmUniqueID>
<ISSNLinking>0885-3185</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>01K63SUP8D</RegistryNumber>
<NameOfSubstance UI="D005473">Fluoxetine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>14611-51-9</RegistryNumber>
<NameOfSubstance UI="D012642">Selegiline</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D003866">Depressive Disorder</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004305">Dose-Response Relationship, Drug</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004334">Drug Administration Schedule</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004359">Drug Therapy, Combination</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D005473">Fluoxetine</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D010300">Parkinson Disease</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D012642">Selegiline</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1995</Year>
<Month>5</Month>
<Day>1</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>1995</Year>
<Month>5</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>1995</Year>
<Month>5</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">7651457</ArticleId>
<ArticleId IdType="doi">10.1002/mds.870100322</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004976 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 004976 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:7651457
   |texte=   Selegiline, fluoxetine, and depression in Parkinson's disease.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:7651457" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a MovDisordV3

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Selegiline, fluoxetine, and depression in Parkinson's disease.

Selegiline, fluoxetine, and depression in Parkinson's disease.

Source :

English descriptors

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki